azacitidine has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, S; Liang, B; Ming, X; Rong, J; Xiang, Y; Xu, X; Yang, G; Zhang, X; Zheng, F | 1 |
| Kotamraju, S; Kutala, VK; Lakshmi, SV; Naushad, SM; Rao, DS; Reddy, CA; Saumya, K | 1 |
2 other study(ies) available for azacitidine and Coronary Artery Disease
| Article | Year |
|---|---|
Thioredoxin-interacting protein promotes activation and inflammation of monocytes with DNA demethylation in coronary artery disease.
Topics: 3' Untranslated Regions; Aged; Azacitidine; Biomarkers; Carrier Proteins; Case-Control Studies; Coronary Artery Disease; DNA Demethylation; Female; Foam Cells; Humans; Inflammation; Male; Middle Aged; Monocytes; RNA, Messenger; THP-1 Cells | 2020 |
Oxidative stress in coronary artery disease: epigenetic perspective.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Cell Line; Coronary Artery Disease; Decitabine; DNA Methylation; Endothelial Cells; Epigenesis, Genetic; Female; Ferredoxin-NADP Reductase; Folic Acid; Glutathione S-Transferase pi; Glycine Hydroxymethyltransferase; Homocysteine; Humans; Hydroxamic Acids; Male; Malondialdehyde; Membrane Proteins; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidative Stress; Promoter Regions, Genetic; Protein Carbonylation; Proto-Oncogene Proteins; Superoxide Dismutase; Young Adult | 2013 |